Invention Grant
- Patent Title: Substituted biaryl sulfonamides and the use thereof
-
Application No.: US17353681Application Date: 2021-06-21
-
Publication No.: US11713293B2Publication Date: 2023-08-01
- Inventor: Leah M. Fung , Kyle W. H. Chan , Cathy A. Swindlehurst , Robert W. Sullivan
- Applicant: NovoMedix, LLC
- Applicant Address: US CA San Diego
- Assignee: NovoMedix, LLC
- Current Assignee: NovoMedix, LLC
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- The original application number of the division: US16674943 2019.11.05
- Main IPC: C07C311/21
- IPC: C07C311/21 ; A61K31/18 ; A61K31/337 ; A61K45/06

Abstract:
Provided herein are substituted biaryl sulfonamide compounds, pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or amelioration of various disorders, including cancer and proliferative disorders. In one embodiment, the compounds provided herein modulate initiation of protein translation. In one embodiment, the compounds provided herein are used in combination with surgery, radiation therapy, immuno therapy and/or one or more additional anticancer drugs for the treatment, prevention, and/or amelioration of cancer and proliferative disorders.
Public/Granted literature
- US20220002240A1 SUBSTITUTED BIARYL SULFONAMIDES AND THE USE THEREOF Public/Granted day:2022-01-06
Information query